NDCHealth Annual Meeting Not Scheduled Due to Per-Se Agreement
01 Septembre 2005 - 3:39PM
PR Newswire (US)
ATLANTA, Sept. 1 /PRNewswire-FirstCall/ -- NDCHealth Corporation
(NYSE:NDC) today announced that, in light of the previously
disclosed agreement to be acquired by Per-Se Technologies, Inc.,
the board of directors of NDCHealth has decided not to schedule an
annual meeting of stockholders prior to the special meeting that
will be called to act upon the acquisition. The transaction with
Per-Se is expected to close within three to six months. NDCHealth
is a leading information solutions company serving all sectors of
healthcare. Its network solutions automate the exchange of
information among pharmacies, payers, hospitals and physicians. Its
systems and information management solutions help improve
operational efficiencies and business decision making for
providers, retail pharmacy and pharmaceutical manufacturers.
Headquartered at Atlanta, Ga., NDCHealth provides information vital
to the delivery of healthcare every day. For more information,
visit http://www.ndchealth.com/ . This communication is being made
in respect of the proposed acquisition transaction involving
NDCHealth Corporation and Per-Se Technologies. This communication
shall not constitute an offer of any securities for sale. In
connection with the proposed transaction, NDCHealth Corporation and
Per-Se Technologies will prepare a registration statement on Form
S-4 containing a joint proxy statement/prospectus for the
shareholders of both companies to be filed with the SEC, and each
will be filing other documents regarding the proposed transaction
with the SEC as well. Before making any voting or investment
decision, investors are urged to read the joint proxy
statement/prospectus regarding the proposed transaction and any
other relevant documents carefully in their entirety when they
become available, as well as any amendments and supplements
thereto, as they will contain important information about the
proposed transaction. The final joint proxy statement/prospectus
will be mailed to the shareholders of both NDCHealth and Per-Se.
You may obtain copies of all documents filed with the SEC regarding
this transaction, free of charge, at the SEC's website (
http://www.sec.gov/ ). You may also obtain these documents, free of
charge, from NDCHealth's website ( http://www.ndchealth.com/ )
under the tab "investor Relations" through the "SEC Filing" link.
You may also obtain these documents, free of charge, from Per-Se's
website ( http://www.per-se.com/ ) under the tab "Investors"
through the "SEC Filing" link. NDCHealth Corporation and Per-Se
Technologies and their respective directors and executive officers
may be deemed participants in the solicitation of proxies from
stockholders in connection with this transaction. Information about
the directors and executive officers of NDCHealth and Per-Se
Technologies and information about other persons who may be deemed
participants in this transaction will be included in the joint
proxy statement/prospectus. You can find information about
NDCHealth's executive officers and directors in NDCHealth's
definitive proxy statement filed with the SEC on September 15,
2004. You can find information about Per-Se Technologies' executive
officers and directors in Per-Se's definitive proxy statement filed
with the SEC on March 25, 2005. DATASOURCE: NDCHealth Corporation
CONTACT: Robert Borchert, VP-Investor Relations of NDCHealth
Corporation, +1-404-728-2906, or Web site:
http://www.ndchealth.com/ http://www.per-se.com/
Copyright
Ndchealth (NYSE:NDC)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024
Ndchealth (NYSE:NDC)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024
Real-Time news about Ndchealth Corp (New York Stock Exchange): 0 recent articles
Plus d'articles sur Ndchealth Corp